Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
A pilot study to compare the efficacy and safety of raltegravir-based versus efavirenz-based
combination therapy in treatment-naïve patients with HIV-1 infection.